Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013, Article ID 317934, 8 pages
http://dx.doi.org/10.1155/2013/317934
Clinical Study

NP-59 SPECT/CT Imaging in Stage 1 Hypertensive and Atypical Primary Aldosteronism: A 5-Year Retrospective Analysis of Clinicolaboratory and Imaging Features

1Division of Nephrology, Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, No. 2 Minsheng Road, Dalin Township, Chiayi County 622, Taiwan
2School of Medicine, Tzu Chi University, Hualien 97004, Taiwan
3Department of Nuclear Medicine, Saint Paul's Hospital, Taoyuan City 330, Taiwan
4Department of Nuclear Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi 622, Taiwan

Received 18 August 2013; Accepted 18 September 2013

Academic Editors: P. Hartvig and O. Schillaci

Copyright © 2013 Yi-Chun Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Mattsson and W. F. Young Jr., “Primary aldosteronism: diagnostic and treatment strategies,” Nature Clinical Practice Nephrology, vol. 2, no. 4, pp. 198–208, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. G. P. Rossi, G. Bernini, C. Caliumi et al., “A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients,” Journal of the American College of Cardiology, vol. 48, no. 11, pp. 2293–2300, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. J. W. Funder, R. M. Carey, C. Fardella et al., “Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 9, pp. 3266–3281, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Lenfant, A. V. Chobanian, D. W. Jones, and E. J. Roccella, “Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails,” Hypertension, vol. 41, no. 6, pp. 1178–1179, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Mosso, C. Carvajal, A. González et al., “Primary aldosteronism and hypertensive disease,” Hypertension, vol. 42, no. 2, pp. 161–165, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. C. E. Fardella, L. Mosso, C. Gómez-Sánchez et al., “Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 5, pp. 1863–1867, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Médeau, F. Moreau, L. Trinquart et al., “Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases,” Clinical Endocrinology, vol. 69, no. 1, pp. 20–28, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Ito, R. Takeda, S. Karashima, Y. Yamamoto, T. Yoneda, and Y. Takeda, “Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects,” Hypertension Research, vol. 34, no. 1, pp. 98–102, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Ito, R. Takeda, and Y. Takeda, “Subclinical primary aldosteronism,” Best Practice & Research Clinical Endocrinology & Metabolism, vol. 26, no. 4, pp. 485–495, 2012. View at Publisher · View at Google Scholar
  10. R. S. Vasan, J. C. Evans, M. G. Larson et al., “Serum aldosterone and the incidence of hypertension in nonhypertensive persons,” The New England Journal of Medicine, vol. 351, no. 1, pp. 33–41, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Ignatowska-Świtalska, J. Chodakowska, W. Januszewicz, T. Feltynowski, M. Adamczyk, and J. Lewandowski, “Evaluation of plasma aldosterone to plasma renin activity ratio in patients with primary aldosteronism,” Journal of Human Hypertension, vol. 11, no. 6, pp. 373–378, 1997. View at Google Scholar · View at Scopus
  12. P. O. Lim, R. T. Jung, and T. M. MacDonald, “Is aldosterone the missing link in refractory hypertension? Aldosterone-to-renin ratio as a marker of inappropriate aldosterone activity,” Journal of Human Hypertension, vol. 16, no. 3, pp. 153–158, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. P. O. Lim, A. D. Struthers, and T. M. MacDonald, “The neurohormonal natural history of essential hypertension: towards primary or tertiary aldosteronism?” Journal of Hypertension, vol. 20, no. 1, pp. 11–15, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. S. A. R. Doi, S. Abalkhail, M. M. Al-Qudhaiby, K. Al-Humood, M. F. Hafez, and K. A. S. Al-Shoumer, “Optimal use and interpretation of the aldosterone renin ratio to detect aldosterone excess in hypertension,” Journal of Human Hypertension, vol. 20, no. 7, pp. 482–489, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Lumachi, M. C. Marzola, P. Zucchetta et al., “Non-invasive adrenal imaging in primary aldosteronism. Sensitivity and positive predictive value of radiocholesterol scintigraphy, CT scan and MRI,” Nuclear Medicine Communications, vol. 24, no. 6, pp. 683–688, 2003. View at Google Scholar · View at Scopus
  16. Y. C. Chen, C. K. Wei, P. F. Chen, J. E. Tzeng, T. L. Chuang, and Y. F. Wang, “Seeking the invisible: I-131 NP-59 SPECT/CT for primary hyperaldosteronism,” Kidney International, vol. 75, no. 6, p. 663, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Ganguly, “Primary aldosteronism,” The New England Journal of Medicine, vol. 339, no. 25, pp. 1828–1834, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. R. F. Yen, V. C. Wu, K. L. Liu et al., “131I-6β-iodomethyl-19-norcholesterol SPECT/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results,” Journal of Nuclear Medicine, vol. 50, no. 10, pp. 1631–1637, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. A. K. Buck, S. Nekolla, S. Ziegler et al., “SPECT/CT,” Journal of Nuclear Medicine, vol. 49, no. 8, pp. 1305–1319, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. M. D. Gross, A. Avram, L. M. Fig, and D. Rubello, “Contemporary adrenal scintigraphy,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 34, no. 4, pp. 547–557, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. C. Chen, J. S. Chiu, C. E. Tseng, and Y. C. Chen, “Use of NP-59 SPECT/CT imaging in atypical primary aldosteronism,” Quarterly Journal of Medicine, 2013. View at Publisher · View at Google Scholar
  22. A. M. Avram, L. M. Fig, and M. D. Gross, “Adrenal gland scintigraphy,” Seminars in Nuclear Medicine, vol. 36, no. 3, pp. 212–227, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Giacchetti, P. Mulatero, F. Mantero, F. Veglio, M. Boscaro, and F. Fallo, “Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis,” Trends in Endocrinology and Metabolism, vol. 19, no. 3, pp. 104–108, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. C. Chen, Y. C. Su, C. K. Wei et al., “Diagnostic value of I-131 NP-59 SPECT/CT scintigraphy in patients with subclinical or atypical features of primary aldosteronism,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 209787, 9 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Beuschlein, “Adrenal incidentalomas: presentation and clinical work-up,” Hormone Research, vol. 68, supplement 5, pp. 191–194, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Douma, K. Petidis, M. Doumas et al., “Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study,” The Lancet, vol. 371, no. 9628, pp. 1921–1926, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. G. P. Rossi, A. C. Pessina, and A. M. Heagerty, “Primary aldosteronism: an update on screening, diagnosis and treatment,” Journal of Hypertension, vol. 26, no. 4, pp. 613–621, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Bhargava, G. He, A. Samarghandi, and E. S. Delpassand, “Pictorial review of SPECT/CT imaging applications in clinical nuclear medicine,” American Journal of Nuclear Medicine and Molecular Imaging, vol. 2, no. 2, pp. 221–231, 2012. View at Google Scholar
  29. P. J. Roach, G. P. Schembri, I. A. Ho Shon, E. A. Bailey, and D. L. Bailey, “SPECT/CT imaging using a spiral CT scanner for anatomical localization: impact on diagnostic accuracy and reporter confidence in clinical practice,” Nuclear Medicine Communications, vol. 27, no. 12, pp. 977–987, 2006. View at Publisher · View at Google Scholar · View at Scopus